- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266069
PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza) (pro-Spinoza)
November 27, 2017 updated by: Bert Leysen
Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium
It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition.
The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Antwerp, Belgium
- Palliatieve Hulpverlening Antwerpen
-
Brussels-Capital Region, Belgium
- Palliabru
-
-
Hainaut
-
Mons, Hainaut, Belgium
- Reliance
-
-
Limburg
-
Hasselt, Limburg, Belgium
- Netwerk Palliatieve Zorg Limburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.
Exclusion Criteria:
- not having signed the informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Research cluster 1: Antwerp
The first Dutch-speaking research cluster in a stepped wedge cluster design.
Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2014.
|
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Other Names:
|
|
Other: Research cluster 2: Mons
The first French-speaking research cluster in a stepped wedge cluster design.
Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from November 2014.
|
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Other Names:
|
|
Other: Research cluster 3: Brussels
The only bilingual Dutch/French-speaking research cluster in a stepped wedge cluster design.
Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from December 2014.
|
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Other Names:
|
|
Other: Research cluster 4: Limburg
The second Dutch-speaking research cluster in a stepped wedge cluster design.
Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from April 2015.
|
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Other Names:
|
|
Other: Research cluster 5: ?
A second French-speaking research cluster in a stepped wedge cluster design.
Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2015.
|
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)
Time Frame: 6 months
|
The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)
Time Frame: 6 months
|
The hypothesis is that the CPPPC reduces the cost of health care consumption in the last year of life
|
6 months
|
|
consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)
Time Frame: 6 months
|
The hypothesis is that the CPPPC reduces the consumption of antibiotics in the last year of life
|
6 months
|
|
consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)
Time Frame: 6 months
|
The hypothesis is that the CPPPC augments the consumption of pain killers in the last year of life
|
6 months
|
|
consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)
Time Frame: 6 months
|
The hypothesis is that the CPPPC reduces the consumption of (invasive) diagnostic and therapeutic procedures in the last year of life
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Bart Van den Eynden, MD, PhD, Universiteit Antwerpen
- Principal Investigator: Johan Wens, MD, PhD, Universiteit Antwerpen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Leysen B, Van den Eynden B, Janssens A, Wens J. Recruiting general practitioners for palliative care research in primary care: real-life barriers explained. BMC Fam Pract. 2019 Mar 5;20(1):40. doi: 10.1186/s12875-019-0930-y.
- Leysen B, Van den Eynden B, Gielen B, Bastiaens H, Wens J. Implementation of a Care Pathway for Primary Palliative Care in 5 research clusters in Belgium: quasi-experimental study protocol and innovations in data collection (pro-SPINOZA). BMC Palliat Care. 2015 Sep 28;14:46. doi: 10.1186/s12904-015-0043-x.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
October 10, 2014
First Submitted That Met QC Criteria
October 10, 2014
First Posted (Estimate)
October 16, 2014
Study Record Updates
Last Update Posted (Actual)
November 29, 2017
Last Update Submitted That Met QC Criteria
November 27, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UA C130298
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palliative Care
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPalliative Care | Palliative Medicine | Hospice and Palliative Care NursingItaly
-
University Medical Center GoettingenRecruitingPalliative Care | Palliative Care, Patient Care | Oral Health Care | Oral Health-Related Quality of LifeGermany
-
Norfolk and Norwich University Hospitals NHS Foundation...Manchester Centre for Genomic Medicine - St. Mary's Hospital University of...Enrolling by invitationPalliative Care | Supportive CareUnited Kingdom
-
Mayo ClinicCompletedPalliative Care | Transitional CareUnited States
-
McMaster UniversityUnknownPalliative Care | Satisfaction | Primary CareCanada
-
Bandırma Onyedi Eylül UniversityEge UniversityRecruitingPalliative CareTurkey
-
Cudeca Hospice FoundationLa Caixa FoundationRecruiting
-
Fordham UniversityCalvary Hospital, Bronx, NYNot yet recruiting
-
University Hospitals of Derby and Burton NHS Foundation...University Hospitals, LeicesterCompleted
-
Centre Hospitalier William Morey - Chalon sur SaôneCompleted
Clinical Trials on Care Pathway for Primary Palliative Care
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
Mayo ClinicCompletedPalliative CareUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Aberystwyth UniversityWithdrawn
-
Umeå UniversityCompleted
-
Massachusetts General HospitalAmerican Society of Transplantation and Cellular TherapyRecruitingHematologic Malignancy | Hematopoietic Cell TransplantUnited States
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
European Pathway AssociationKU LeuvenCompleted
-
University of AlbertaOttawa Hospital Research Institute; University of Calgary; Alberta Innovates... and other collaboratorsCompleted